Organon & Co. Statistics
Share Statistics
Organon & Co. has 257.54M shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 257.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.12% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 256.98M |
| Failed to Deliver (FTD) Shares | 39.78K |
| FTD / Avg. Volume | 1.52% |
Short Selling Information
The latest short interest is 14.15M, so 5.49% of the outstanding shares have been sold short.
| Short Interest | 14.15M |
| Short % of Shares Out | 5.49% |
| Short % of Float | 5.51% |
| Short Ratio (days to cover) | 6.54 |
Valuation Ratios
The PE ratio is 3.6 and the forward PE ratio is 3.68.
| PE Ratio | 3.6 |
| Forward PE | 3.68 |
| PS Ratio | 0.59 |
| Forward PS | 0.6 |
| PB Ratio | -52.58 |
| P/FCF Ratio | 6.84 |
| PEG Ratio | n/a |
Enterprise Valuation
Organon & Co. has an Enterprise Value (EV) of 11.75B.
| EV / Earnings | 11.48 |
| EV / Sales | 1.88 |
| EV / EBITDA | 8.18 |
| EV / EBIT | 8.85 |
| EV / FCF | 21.84 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of -125.14.
| Current Ratio | 1.54 |
| Quick Ratio | 1.09 |
| Debt / Equity | -125.14 |
| Total Debt / Capitalization | 100.81 |
| Cash Flow / Debt | 0.09 |
| Interest Coverage | 2.52 |
Financial Efficiency
Return on equity (ROE) is -14.61% and return on capital (ROIC) is 23.21%.
| Return on Equity (ROE) | -14.61% |
| Return on Assets (ROA) | 0.08% |
| Return on Capital (ROIC) | 23.21% |
| Revenue Per Employee | 626.30K |
| Profits Per Employee | 102.30K |
| Employee Count | 10.00K |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.91 |
Taxes
| Income Tax | -350.00M |
| Effective Tax Rate | -0.52 |
Stock Price Statistics
The stock price has increased by 17.13% in the last 52 weeks. The beta is 0.8, so Organon & Co.'s price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | 17.13% |
| 50-Day Moving Average | 16.57 |
| 200-Day Moving Average | 19.12 |
| Relative Strength Index (RSI) | 44.08 |
| Average Volume (20 Days) | 2.61M |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.26B and earned $1.02B in profits. Earnings per share was $4.01.
| Revenue | 6.26B |
| Gross Profit | 3.75B |
| Operating Income | 1.33B |
| Net Income | 1.02B |
| EBITDA | 1.44B |
| EBIT | 1.33B |
| Earnings Per Share (EPS) | 4.01 |
Balance Sheet
The company has $693.00M in cash and $8.76B in debt, giving a net cash position of -$8.07B.
| Cash & Cash Equivalents | 693.00M |
| Total Debt | 8.76B |
| Net Cash | -8.07B |
| Retained Earnings | 443.00M |
| Total Assets | 12.75B |
| Working Capital | 1.97B |
Cash Flow
In the last 12 months, operating cash flow was $799.00M and capital expenditures -$261.00M, giving a free cash flow of $538.00M.
| Operating Cash Flow | 799.00M |
| Capital Expenditures | -261.00M |
| Free Cash Flow | 538.00M |
| FCF Per Share | 2.11 |
Margins
Gross margin is 59.84%, with operating and profit margins of 21.19% and 16.33%.
| Gross Margin | 59.84% |
| Operating Margin | 21.19% |
| Pretax Margin | 10.75% |
| Profit Margin | 16.33% |
| EBITDA Margin | 22.93% |
| EBIT Margin | 21.19% |
| FCF Margin | 8.59% |
Dividends & Yields
OGN pays an annual dividend of $1.12, which amounts to a dividend yield of 7.3%.
| Dividend Per Share | $1.12 |
| Dividend Yield | 7.3% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 22.18% |
| Earnings Yield | 26.17% |
| FCF Yield | 13.64% |
Analyst Forecast
The average price target for OGN is $20, which is 30.5% higher than the current price. The consensus rating is "Sell".
| Price Target | $20 |
| Price Target Difference | 30.5% |
| Analyst Consensus | Sell |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 1.36 |
| Piotroski F-Score | 4 |